Category Archives: cbd treatments for breast cancer

Marijuana Effects 2019: 10 Medical Benefits Of Cannabis That Will Surprise You – Medical Daily
17 Mar
12:44

Marijuana Effects 2019: 10 Medical Benefits Of Cannabis That Will Surprise You – Medical Daily

There has been a growing number of Americans sharing the same opinion on legalizing marijuana across the U.S. According to a 2018 Pew Research Center survey, six in 10 citizens, or 62 percent of the population, already accepted the medical benefits of cannabis and are supporting its nationwide legalization.  In the […]

Intec Pharma Ltd. (NTEC) and Corcept Therapeutics Incorporated (NASDAQ:CORT) Comparing side by side – Standard Recorder
15 Mar
8:15

Intec Pharma Ltd. (NTEC) and Corcept Therapeutics Incorporated (NASDAQ:CORT) Comparing side by side – Standard Recorder

Intec Pharma Ltd. (NASDAQ:NTEC) and Corcept Therapeutics Incorporated (NASDAQ:CORT) compete against each other in the Biotechnology sector. We will contrast them and contrast their analyst recommendations, profitability, institutional ownership, risk, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Intec Pharma […]

ZEB1 throttles therapeutic target, protecting KRAS-mutant lung cancer – Newswise
14 Mar
3:04

ZEB1 throttles therapeutic target, protecting KRAS-mutant lung cancer – Newswise

<!—-> <!– « Return to article list –> Return to Article List Next Article > ZEB1 throttles therapeutic target, protecting KRAS-mutant lung cancer Protein forces a shift in cell type, a plasticity that promotes resistance to targeted therapy Article ID: 709592 Released: 13-Mar-2019 3:05 PM EDT Source Newsroom: University of […]

Odonate Therapeutics Inc. (ODT)’s Financial Results Comparing With Intec Pharma Ltd. (NASDAQ:NTEC) – EN Digest
14 Mar
1:54

Odonate Therapeutics Inc. (ODT)’s Financial Results Comparing With Intec Pharma Ltd. (NASDAQ:NTEC) – EN Digest

Both Odonate Therapeutics Inc. (NASDAQ:ODT) and Intec Pharma Ltd. (NASDAQ:NTEC) are each other’s competitor in the Biotechnology industry. Thus the compare of their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Odonate Therapeutics Inc. […]

aTyr Pharma (NASDAQ:LIFE) Receives a Higher Rating From BidaskScore. Is it Time to Buy Shares? | Thorold News – Thorold News
13 Mar
3:49

aTyr Pharma (NASDAQ:LIFE) Receives a Higher Rating From BidaskScore. Is it Time to Buy Shares? | Thorold News – Thorold News

aTyr Pharma (NASDAQ:LIFE) Stock Upgrade In a research note shared with investors on Wednesday morning, BidaskScore announced that they have decided to upgrade aTyr Pharma (NASDAQ:LIFE) shares to a “Sell”. The stock decreased 0.75% or $0.0035 during the last trading session, reaching $0.4612. About 298,381 shares traded or 15.66% up […]

Trust Company Of Virginia Has Trimmed Abbvie (ABBV) Stake by $386,860; Towle & Co Increases Position in M/I Homes (MHO) – The FinExaminer
13 Mar
5:25

Trust Company Of Virginia Has Trimmed Abbvie (ABBV) Stake by $386,860; Towle & Co Increases Position in M/I Homes (MHO) – The FinExaminer

Trust Company Of Virginia decreased its stake in Abbvie Inc (ABBV) by 21.35% based on its latest 2018Q4 regulatory filing with the SEC. Trust Company Of Virginia sold 4,205 shares as the company’s stock declined 10.66% while stock markets rallied. The institutional investor held 15,489 shares of the major pharmaceuticals […]

First Quadrant LP Upped Futurefuel (FF) Holding by $692,790; Holder US Global Investors Raised Abbvie (ABBV) Holding – The FinHeadLines
12 Mar
7:17

First Quadrant LP Upped Futurefuel (FF) Holding by $692,790; Holder US Global Investors Raised Abbvie (ABBV) Holding – The FinHeadLines

U S Global Investors Inc increased its stake in Abbvie Inc (ABBV) by 315.11% based on its latest 2018Q4 regulatory filing with the SEC. U S Global Investors Inc bought 13,830 shares as the company’s stock declined 10.66% while stock markets rallied. The institutional investor held 18,219 shares of the […]

Earth Science Tech, Inc. Signs Distributor for Hygee™ and Provides Update on CBD Product Launch – GlobeNewswire
12 Mar
8:59

Earth Science Tech, Inc. Signs Distributor for Hygee™ and Provides Update on CBD Product Launch – GlobeNewswire

DORAL, Florida, Feb. 13, 2019 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTCQB: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces a distribution agreement to market its Hygee™ medical device in Vietnam, […]

Neon Therapeutics Inc. (NTGN) and Intec Pharma Ltd. (NASDAQ:NTEC) Contrasting side by side – The FinExaminer
10 Mar
6:26

Neon Therapeutics Inc. (NTGN) and Intec Pharma Ltd. (NASDAQ:NTEC) Contrasting side by side – The FinExaminer

As Biotechnology companies, Neon Therapeutics Inc. (NASDAQ:NTGN) and Intec Pharma Ltd. (NASDAQ:NTEC) are our subject to compare. And more specifically their analyst recommendations, profitability, risk, dividends, earnings and valuation, institutional ownership. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Neon Therapeutics Inc. N/A 0.00 […]

Reviewing Intec Pharma Ltd. (NTEC)’s and GTx Inc. (NASDAQ:GTXI)’s results – Lives Advice
09 Mar
8:04

Reviewing Intec Pharma Ltd. (NTEC)’s and GTx Inc. (NASDAQ:GTXI)’s results – Lives Advice

We are contrasting Intec Pharma Ltd. (NASDAQ:NTEC) and GTx Inc. (NASDAQ:GTXI) on their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. They both are Biotechnology companies, competing one another. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Intec Pharma Ltd. N/A 0.00 […]